Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)

Evandro Fei Fang; Lynn Froetscher; Morten Scheibye-Knudsen; Vilhelm A Bohr; Jack Ho Wong; Tzi Bun Ng

doi:10.2174/1389203719666180622095800

Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)

Evandro Fei Fang, Lynn Froetscher, Morten Scheibye-Knudsen, Vilhelm A Bohr, Jack Ho Wong, Tzi Bun Ng

5 Citationer (Scopus)

Abstract

Bitter melon or bitter gourd (Momordica charantia) is a common vegetable in Asia and it is distinctive for its bitter taste. As an ingredient in folk medicine, research from different laboratories in recent years supports its potential medicinal applications with anti-tumor, anti-diabetic, anti-HIV activities in both in vitro and animal studies. In this short review, we summarize herein the recent progress in the antitumor aspect of bitter melon with a focus on the underlying molecular mechanisms. Further mechanistic studies as well as clinical trials are necessary to further verify its medicinal applications.

Originalsprog	Engelsk
Tidsskrift	Current Protein and Peptide Science
Vol/bind	20
Udgave nummer	3
Sider (fra-til)	296-301
Antal sider	6
ISSN	1389-2037
DOI	https://doi.org/10.2174/1389203719666180622095800
Status	Udgivet - 2019
Udgivet eksternt	Ja

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.2174/1389203719666180622095800

Citationsformater

@article{06301c7977fa4e08a2859b21db4b8a6d,

title = "Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)",

abstract = "Bitter melon or bitter gourd (Momordica charantia) is a common vegetable in Asia and it is distinctive for its bitter taste. As an ingredient in folk medicine, research from different laboratories in recent years supports its potential medicinal applications with anti-tumor, anti-diabetic, anti-HIV activities in both in vitro and animal studies. In this short review, we summarize herein the recent progress in the antitumor aspect of bitter melon with a focus on the underlying molecular mechanisms. Further mechanistic studies as well as clinical trials are necessary to further verify its medicinal applications.",

author = "Fang, {Evandro Fei} and Lynn Froetscher and Morten Scheibye-Knudsen and Bohr, {Vilhelm A} and Wong, {Jack Ho} and Ng, {Tzi Bun}",

note = "Copyright{\textcopyright} Bentham Science Publishers; For any queries, please email at [email protected].",

year = "2019",

doi = "10.2174/1389203719666180622095800",

language = "English",

volume = "20",

pages = "296--301",

journal = "Current Protein and Peptide Science",

issn = "1389-2037",

publisher = "Bentham Science Publishers",

number = "3",

}

TY - JOUR

T1 - Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)

AU - Fang, Evandro Fei

AU - Froetscher, Lynn

AU - Scheibye-Knudsen, Morten

AU - Bohr, Vilhelm A

AU - Wong, Jack Ho

AU - Ng, Tzi Bun

PY - 2019

Y1 - 2019

N2 - Bitter melon or bitter gourd (Momordica charantia) is a common vegetable in Asia and it is distinctive for its bitter taste. As an ingredient in folk medicine, research from different laboratories in recent years supports its potential medicinal applications with anti-tumor, anti-diabetic, anti-HIV activities in both in vitro and animal studies. In this short review, we summarize herein the recent progress in the antitumor aspect of bitter melon with a focus on the underlying molecular mechanisms. Further mechanistic studies as well as clinical trials are necessary to further verify its medicinal applications.

AB - Bitter melon or bitter gourd (Momordica charantia) is a common vegetable in Asia and it is distinctive for its bitter taste. As an ingredient in folk medicine, research from different laboratories in recent years supports its potential medicinal applications with anti-tumor, anti-diabetic, anti-HIV activities in both in vitro and animal studies. In this short review, we summarize herein the recent progress in the antitumor aspect of bitter melon with a focus on the underlying molecular mechanisms. Further mechanistic studies as well as clinical trials are necessary to further verify its medicinal applications.

U2 - 10.2174/1389203719666180622095800

DO - 10.2174/1389203719666180622095800

M3 - Journal article

C2 - 29932035

SN - 1389-2037

VL - 20

SP - 296

EP - 301

JO - Current Protein and Peptide Science

JF - Current Protein and Peptide Science

IS - 3

ER -

Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater